SHEFALI PATEL: Open Payments
NPI 1902488125 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,642 in 99 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $632 · 2025 $1,642
Food & beverage: $1,642
| Company | Payments | Amount |
|---|---|---|
| Forte Bio-Pharma LLC | 27 | $348 |
| Collegium Pharmaceutical, Inc. | 21 | $260 |
| ABBVIE INC. | 13 | $258 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $97 |
| Nalu Medical, Inc. | 3 | $89 |
| SCILEX PHARMACEUTICALS INC. | 5 | $83 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $82 |
| PFIZER INC. | 4 | $75 |
| Azurity Pharmaceuticals, Inc. | 3 | $65 |
| Valinor Pharma, LLC | 3 | $51 |
Products named: PROLATE, QULIPTA, XTAMPZA, Belbuca, JOURNAVX, Nalu Neurostimulation System, RELISTOR, HORIZANT.
Industry payments across TX — which companies pay providers there.
